These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35169219)

  • 1. A small molecule high throughput screening platform to profile conformational properties of nascent, ribosome-bound proteins.
    Shishido H; Yoon JS; Skach WR
    Sci Rep; 2022 Feb; 12(1):2509. PubMed ID: 35169219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates.
    Shishido H; Yoon JS; Yang Z; Skach WR
    Nat Commun; 2020 Aug; 11(1):4258. PubMed ID: 32848127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-driven vectorial folding of ribosome-bound human CFTR NBD1.
    Khushoo A; Yang Z; Johnson AE; Skach WR
    Mol Cell; 2011 Mar; 41(6):682-92. PubMed ID: 21419343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    Chung WJ; Goeckeler-Fried JL; Havasi V; Chiang A; Rowe SM; Plyler ZE; Hong JS; Mazur M; Piazza GA; Keeton AB; White EL; Rasmussen L; Weissman AM; Denny RA; Brodsky JL; Sorscher EJ
    PLoS One; 2016; 11(10):e0163615. PubMed ID: 27732613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.
    Lewis HA; Zhao X; Wang C; Sauder JM; Rooney I; Noland BW; Lorimer D; Kearins MC; Conners K; Condon B; Maloney PC; Guggino WB; Hunt JF; Emtage S
    J Biol Chem; 2005 Jan; 280(2):1346-53. PubMed ID: 15528182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.
    Hall JD; Wang H; Byrnes LJ; Shanker S; Wang K; Efremov IV; Chong PA; Forman-Kay JD; Aulabaugh AE
    Protein Sci; 2016 Feb; 25(2):360-73. PubMed ID: 26444971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening.
    Kalid O; Mense M; Fischman S; Shitrit A; Bihler H; Ben-Zeev E; Schutz N; Pedemonte N; Thomas PJ; Bridges RJ; Wetmore DR; Marantz Y; Senderowitz H
    J Comput Aided Mol Des; 2010 Dec; 24(12):971-91. PubMed ID: 20976528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR.
    Smith E; Dukovski D; Shumate J; Scampavia L; Miller JP; Spicer TP
    SLAS Discov; 2021 Feb; 26(2):205-215. PubMed ID: 33016182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening of libraries of compounds to identify CFTR modulators.
    Pedemonte N; Zegarra-Moran O; Galietta LJ
    Methods Mol Biol; 2011; 741():13-21. PubMed ID: 21594775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 Reporter.
    Phuan PW; Veit G; Tan JA; Roldan A; Finkbeiner WE; Haggie PM; Lukacs GL; Verkman AS
    SLAS Discov; 2018 Sep; 23(8):823-831. PubMed ID: 29533733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple image-based no-wash method for quantitative detection of surface expressed CFTR.
    Larsen MB; Hu J; Frizzell RA; Watkins SC
    Methods; 2016 Mar; 96():40-45. PubMed ID: 26361332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly.
    He L; Aleksandrov AA; An J; Cui L; Yang Z; Brouillette CG; Riordan JR
    J Mol Biol; 2015 Jan; 427(1):106-20. PubMed ID: 25083918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein folding. Translational tuning optimizes nascent protein folding in cells.
    Kim SJ; Yoon JS; Shishido H; Yang Z; Rooney LA; Barral JM; Skach WR
    Science; 2015 Apr; 348(6233):444-8. PubMed ID: 25908822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis.
    Thibodeau PH; Richardson JM; Wang W; Millen L; Watson J; Mendoza JL; Du K; Fischman S; Senderowitz H; Lukacs GL; Kirk K; Thomas PJ
    J Biol Chem; 2010 Nov; 285(46):35825-35. PubMed ID: 20667826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Homogeneous Cell-Based Halide-Sensitive Yellow Fluorescence Protein Assay to Identify Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Ion Channel.
    Smith E; Giuliano KA; Shumate J; Baillargeon P; McEwan B; Cullen MD; Miller JP; Drew L; Scampavia L; Spicer TP
    Assay Drug Dev Technol; 2017 Dec; 15(8):395-406. PubMed ID: 29172645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.
    Yu W; Kim Chiaw P; Bear CE
    J Biol Chem; 2011 Jul; 286(28):24714-25. PubMed ID: 21602569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function.
    Rabeh WM; Bossard F; Xu H; Okiyoneda T; Bagdany M; Mulvihill CM; Du K; di Bernardo S; Liu Y; Konermann L; Roldan A; Lukacs GL
    Cell; 2012 Jan; 148(1-2):150-63. PubMed ID: 22265408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain.
    Odolczyk N; Fritsch J; Norez C; Servel N; da Cunha MF; Bitam S; Kupniewska A; Wiszniewski L; Colas J; Tarnowski K; Tondelier D; Roldan A; Saussereau EL; Melin-Heschel P; Wieczorek G; Lukacs GL; Dadlez M; Faure G; Herrmann H; Ollero M; Becq F; Zielenkiewicz P; Edelman A
    EMBO Mol Med; 2013 Oct; 5(10):1484-501. PubMed ID: 23982976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An energy-dependent maturation step is required for release of the cystic fibrosis transmembrane conductance regulator from early endoplasmic reticulum biosynthetic machinery.
    Oberdorf J; Pitonzo D; Skach WR
    J Biol Chem; 2005 Nov; 280(46):38193-202. PubMed ID: 16166089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation.
    Hutt DM; Loguercio S; Roth DM; Su AI; Balch WE
    J Biol Chem; 2018 Aug; 293(35):13477-13495. PubMed ID: 30006345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.